Symbol
| GATA3
| contributors: mct/pgu - updated : 03-02-2016
|
HGNC name
| GATA binding protein 3
|
HGNC id
| 4172
|
corresponding disease(s)
|
HDR
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --other
|  
|
aberrant expression in pancreatic cancer | tumoral
|  
|  
| --over
|  
|
in ESR1-positive breast tumors | tumoral
|  
|  
| --over
|  
|
during the late secretory phase in the endometrium, suggesting antagonistic function and/or regulation between progesterone receptor and TBX21/GATA3 | |
Susceptibility
|
to Hodgkin lymphoma |
Variant & Polymorphism
SNP
| SNP increasing the risk of Hodgkin lymphoma |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
miscelleaneous | vascular | | |
therapies designed to maintain GATA3 activity might help to blunt the deleterious effects of inflammation on the endothelium |
| | | |
| GATA3 leads to embryonic lethality due to noradrenaline deficiency of the sympathic nervous system,in mice |